Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Michael D. Hadjidaniel"'
Autor:
Soheila Shirinbak, Randall Y. Chan, Shilpa Shahani, Sakunthala Muthugounder, Rebekah Kennedy, Long T. Hung, G. Esteban Fernandez, Michael D. Hadjidaniel, Babak Moghimi, Michael A. Sheard, Alan L. Epstein, Muller Fabbri, Hiroyuki Shimada, Shahab Asgharzadeh
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Immune checkpoint therapy has resulted in minimal clinical response in many pediatric cancers. We sought to understand the influence of immune checkpoint inhibition using anti-PD-1 and anti-CTLA-4 antibodies individually, in combination, and after ch
Externí odkaz:
https://doaj.org/article/0915f141d7a649279983360de71ca579
Autor:
Chrysanthia A Leontiou, Michael D Hadjidaniel, Petros Mina, Pavlos Antoniou, Marios Ioannides, Philippos C Patsalis
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135058 (2015)
Epigenetic alterations, including DNA methylation, play an important role in the regulation of gene expression. Several methods exist for evaluating DNA methylation, but bisulfite sequencing remains the gold standard by which base-pair resolution of
Externí odkaz:
https://doaj.org/article/3c333e59b450416190cc9e0e3dd346f5
Autor:
Alan L. Epstein, Hiroyuki Shimada, Michael D. Hadjidaniel, Babak Moghimi, G. Esteban Fernandez, Randall Y. Chan, Michael A. Sheard, Sakunthala Muthugounder, Shahab Asgharzadeh, Shilpa Shahani, Rebekah J. Kennedy, Soheila Shirinbak, Muller Fabbri, Long T. Hung
Publikováno v:
Oncoimmunology
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
article-version (VoR) Version of Record
OncoImmunology, Vol 10, Iss 1 (2021)
Immune checkpoint therapy has resulted in minimal clinical response in many pediatric cancers. We sought to understand the influence of immune checkpoint inhibition using anti-PD-1 and anti-CTLA-4 antibodies individually, in combination, and after ch
Autor:
Lucia Borriello, Soheila Shirinbak, Michael D. Hadjidaniel, Rebekah J. Kennedy, Hiroshi Iwakura, Hiroyuki Shimada, Takashi Akamizu, Sakunthala Muthugounder, Richard Sposto, Jemily Malvar, Shahab Asgharzadeh, Long T. Hung, Randall Y. Chan, Rie Nakata, Yves A. DeClerck, Michael A. Sheard
Publikováno v:
Oncotarget
// Michael D. Hadjidaniel 1, * , Sakunthala Muthugounder 1, * , Long T. Hung 1, * , Michael A. Sheard 1 , Soheila Shirinbak 1 , Randall Y. Chan 1, 3 , Rie Nakata 1 , Lucia Borriello 1 , Jemily Malvar 1 , Rebekah J. Kennedy 1 , Hiroshi Iwakura 2 , Tak
Autor:
George Koumbaris, Kyriakos Tsangaras, Philippos C. Patsalis, Charalambos Loizides, Carolina Sismani, Marios Ioannides, Petros Mina, Skevi Kyriacou, Elena Kypri, Maria Neofytou, Achilleas Achilleos, Anna Keravnou, Michael D. Hadjidaniel
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0199010 (2018)
PLOS ONE
PLOS ONE
DNA methylation is the most characterized epigenetic process exhibiting stochastic variation across different tissues and individuals. In non-invasive prenatal testing (NIPT) fetal specific methylated regions can potentially be used as biomarkers for
Autor:
Skevi Kyriakou, Elena Kypri, Philippos C. Patsalis, Anna Keravnou, Charalambos Loizides, Maria Neofytou, Marios Ioannides, Elisavet A. Papageorgiou, Achilleas Achilleos, Michael D. Hadjidaniel, Carolina Sismani, Petros Mina, Kyriakos Tsangaras, Pavlos Antoniou, George Koumbaris
Publikováno v:
Genetics Research
SummaryDNA methylation is an epigenetic marker that has been shown to vary significantly across different tissues. Taking advantage of the methylation differences between placenta-derived cell-free DNA and maternal blood, several groups employed diff
Publikováno v:
Molecular Cancer Therapeutics. 9:3164-3174
13-cis-Retinoic acid (13-cis-RA) is given at completion of cytotoxic therapy to control minimal residual disease in neuroblastoma. We investigated the effect of combining 13-cis-RA with cytotoxic agents employed in neuroblastoma therapy using a panel
Autor:
Xinna Zhang, Francesca Fanini, Muller Fabbri, Cristina Ivan, Mariam Murtadha, Ivan Vannini, Hiroyuki Shimada, Petra Wise, Rebekah J. Kennedy, George A. Calin, Tong Xu, Amir Goldkorn, Shahab Asgharzadeh, Michael D. Hadjidaniel, Paolo Neviani, Kishore B. Challagundla, Dino Amadori, Ambrose Jong, Robert C. Seeger, Haritha Chava
Publikováno v:
JNCI: Journal of the National Cancer Institute. 107
Background: How exosomic microRNAs (miRNAs) contribute to the development of drug resistance in the context of the tumor microenvironment has not been previously described in neuroblastoma (NBL). Methods: Coculture experiments were performed to asses
Autor:
Philippos C. Patsalis, Marios Ioannides, Pavlos Antoniou, Chrysanthia A. Leontiou, Petros Mina, Michael D. Hadjidaniel
Publikováno v:
PLOS ONE
PLoS ONE, Vol 10, Iss 8, p e0135058 (2015)
PLoS ONE
PLoS ONE, Vol 10, Iss 8, p e0135058 (2015)
PLoS ONE
Introduction Epigenetic alterations, including DNA methylation, play an important role in the regulation of gene expression. Several methods exist for evaluating DNA methylation, but bisulfite sequencing remains the gold standard by which base-pair r
Autor:
George Koumbaris, Elena Kypri, Philippos C. Patsalis, Elisavet A. Papageorgiou, Michael D. Hadjidaniel
Publikováno v:
Genes
Genes, Vol 5, Iss 2, Pp 310-329 (2014)
Genes, Vol 5, Iss 2, Pp 310-329 (2014)
Epigenetic modifications have proven to play a significant role in cancer development, as well as fetal development. Taking advantage of the knowledge acquired during the last decade, great interest has been shown worldwide in deciphering the fetal e